PRL-8-53
Cognitive · Obscure nootropic
Tier D
Bottom line
Read Off Label grades PRL-8-53 as D (3.3/10) based on very weak evidence, unclear benefit magnitude, and a unclear-risk safety profile.
Synthesized by Nikolaus Hansl at Creighton in the 1970s.
Studied, labeled, or reported-use context: No established modern dosing — Research chem; not individualized guidance.
What the evidence says
Synthesized by Nikolaus Hansl at Creighton in the 1970s. The single human paper reported striking verbal memory improvement but was never replicated in 40+ years. Exemplar of a 'forgotten nootropic' with folkloric reputation and no modern data.
Mechanism
Benzhydryl-based compound; proposed cholinergic and dopaminergic potentiation; mechanism poorly characterized
Studied, labeled, or reported dose & route
No established modern dosing
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about PRL-8-53's effects?
- Read Off Label rates the evidence for PRL-8-53 as Very Weak and the benefit magnitude as unclear, producing an overall grade of D (3.3/10). Synthesized by Nikolaus Hansl at Creighton in the 1970s.
- What safety findings are reported for PRL-8-53?
- PRL-8-53 has a unclear risk profile in the database. Unknown (essentially no safety data) Legal status: Research chem.
- What doses or routes are reported for PRL-8-53?
- No established modern dosing This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does PRL-8-53 work?
- Benzhydryl-based compound; proposed cholinergic and dopaminergic potentiation; mechanism poorly characterized
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.